Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches

Junaid Ullah, Syed Ghulam Musharraf

Open source

DOI
10.1016/j.biopha.2026.119901
Published
2026-10
Container
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2026.119901,
  title = {Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches},
  author = {Junaid Ullah and Syed Ghulam Musharraf},
  year = {2026},
  journal = {Biomedicine \& Pharmacotherapy},
  doi = {10.1016/j.biopha.2026.119901},
  url = {https://doi.org/10.1016/j.biopha.2026.119901}
}

RIS

TY  - JOUR
TI  - Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches
AU  - Junaid Ullah
AU  - Syed Ghulam Musharraf
PY  - 2026
JO  - Biomedicine & Pharmacotherapy
DO  - 10.1016/j.biopha.2026.119901
UR  - https://doi.org/10.1016/j.biopha.2026.119901
ER  - 

APA

Ullah, J., & Musharraf, S. G. (2026). Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119901

Source records